May-Thurner syndrome, a diagnosis to consider in young males with no risk factors: a case report and review of the literature.

J Med Case Rep

Department of Vascular Surgery, The Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC, 3050, Australia.

Published: March 2021

AI Article Synopsis

  • May-Thurner syndrome is a condition where the left common iliac vein is compressed by the right common iliac artery, leading to potential deep vein thrombosis, particularly in young women.
  • A case study of a 23-year-old male with unexplained leg pain revealed he had a deep vein thrombosis linked to May-Thurner syndrome, despite having no typical risk factors.
  • The patient received comprehensive treatment including thrombolysis, stenting, and was later switched to anticoagulation therapy, demonstrating the need for awareness of this syndrome in bizarre cases of venous issues.

Article Abstract

Background: May-Thurner syndrome is an anatomical condition characterized by compression of the left common iliac vein by the right common iliac artery, causing venous outflow obstruction. It is an uncommon cause of deep vein thrombosis and is more prevalent among women. This paper highlights the importance of considering May-Thurner syndrome in young males without risk factors presenting with left lower limb pain, as endovascular treatment may be required.

Case Presentation: A 23 year-old Caucasian male presented with a 1-week history of left lower limb pain, edema, and pallor. He was found to have an unprovoked deep vein thrombosis on Doppler ultrasound involving the left fibular, soleus, gastrocnemius, popliteal, femoral, common femoral, and external iliac veins. A heparin infusion was commenced as the initial treatment for deep vein thrombosis. Further investigation with computer tomography pulmonary angiogram and computer tomography venography of the abdomen and pelvis showed bilateral pulmonary emboli and left common iliac vein compression with left common, internal, and external iliac vein thrombosis. He was diagnosed with May-Thurner syndrome despite having no risk factors. A retrievable Cook Celect Platinum inferior vena cava filter was placed, and thrombus of the left common femoral, external, and common iliac veins was treated successfully with AngioJet thrombectomy, thrombolysis using 200,000 units of urokinase, angioplasty and stenting using two Cook Zilver Vena venous self-expanding stents. Therapeutic enoxaparin was commenced on discharge. His filter was removed after 10 weeks. Hematological follow-up 4 months later showed an overall negative thrombophilia screen, and anticoagulation was switched to apixaban. He has had no recurrent thrombosis.

Conclusions: Clinicians should have a low threshold to investigate for May-Thurner syndrome in patients with left lower limb venous thrombotic events regardless of risk factors, as endovascular treatment may be required to minimize the long-term sequelae of deep vein thrombosis. Duplex ultrasound can be used initially for diagnosis, and computer tomography venography used subsequently if the common iliac vein is not visualized on ultrasound. Endovascular treatment is preferred over anticoagulation alone, especially in otherwise fit patients presenting early, the aim being to reduce the chances of chronic venous hypertension in the lower limb.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977182PMC
http://dx.doi.org/10.1186/s13256-021-02730-8DOI Listing

Publication Analysis

Top Keywords

may-thurner syndrome
20
common iliac
20
vein thrombosis
20
risk factors
16
left common
16
iliac vein
16
deep vein
16
lower limb
16
left lower
12
endovascular treatment
12

Similar Publications

This case report describes a unique presentation of May-Thurner syndrome (MTS) in a 28-year-old woman, characterized by the congenital bifurcation of the left common iliac vein (LCIV) into the outer (OLCIV) and inner (ILCIV) segments. Both veins experienced significant compression - OLCIV proximally and ILCIV medially - due to the overlying right common iliac artery (RCIA) and lumbar spine. The patient presented with bilateral spider veins, lower extremity swelling, pelvic discomfort, and bilateral leg cramping.

View Article and Find Full Text PDF

May-Thurner syndrome, also known as external iliac compression syndrome, is a rare but commonly underdiagnosed cause of asymmetric lower extremity edema. Here we describe a case of May-Thurner syndrome owing to external compression of the right and left common iliac veins presenting as chronic worsening asymmetric right greater than left lower extremity edema. Initial etiology workup was unremarkable, and further diagnostics revealed compression of the right common iliac vein at the bifurcation of the right common iliac artery between the right external and internal iliac arteries with concomitant compression of the left common iliac vein.

View Article and Find Full Text PDF

May-Thurner syndrome is a rare disorder characterized by the right common iliac artery overlies and compresses the left common iliac vein against the lumbar spine with or without iliofemoral deep venous thrombosis (DVT). The majority of cases are female and have been associated with the development of vulvar varicosities, particularly during pregnancy. Interestingly and very rarely, this condition has also been identified as a potential cause of varicoceles in males.

View Article and Find Full Text PDF
Article Synopsis
  • Glofitamab, a bispecific antibody targeting CD20 and CD3, shows promise for treating relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) in heavily pretreated patients, with an overall response rate of 47%.
  • In a study involving 70 patients in Germany, Austria, and Switzerland, the median number of prior treatments was four, with notable safety concerns including cytokine release syndrome in 40% of cases.
  • Important findings indicate that elevated LDH levels predict poorer outcomes, and recent treatment with bendamustine may reduce the efficacy of glofitamab, suggesting careful treatment sequencing is essential.
View Article and Find Full Text PDF

Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) and multiple myeloma have poor outcomes. CAR-T completely changed the landscape of therapy options, improving not only response rates but also survival outcomes. Hematological toxicity after chimeric antigen receptor therapy (CAR-T) is of increasing interest, being a recognized prognostic factor in this setting.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!